bibliographic entry 679251 [be/679251]
https://w3id.org/oc/corpus/be/679251

is a
content
  • FDA Drug Safety Communication: FDA warns that SGLT2 inhibitors for diabetes may result in a serious condition of too much acid in the blood, 5, 15, 2015, Available from, http://www.fda.gov/Drugs/DrugSafety/ucm446845.htm, Accessed October 1, 2015
references